Soft Gelatin Capsules Market Size, Share, Growth, and Industry Analysis, By Type (Dropping Method,Pressing Method), By Application (Pharmaceutical,Health Supplements,Other), Regional Insights and Forecast to 2035

Soft Gelatin Capsules Market Overview

The global Soft Gelatin Capsules Market size is projected to grow from USD 5576.17 million in 2026 to USD 5912.98 million in 2027, reaching USD 9456.37 million by 2035, expanding at a CAGR of 6.04% during the forecast period.

The Soft Gelatin Capsules Market has experienced robust expansion across pharmaceuticals, nutraceuticals, and health supplements. In 2024, over 68% of gelatin capsules consumed globally were classified as soft gels due to their superior bioavailability and patient compliance. Approximately 42 billion soft gelatin capsules are produced annually, with nutraceuticals accounting for 55% of demand and pharmaceuticals contributing 38%. Rising use of omega-3 supplements in encapsulated form has pushed production growth by 18% over the last five years. The market demonstrates significant penetration in over 80 countries, with over 1,200 companies actively engaged in soft gel manufacturing and distribution.

In the United States Soft Gelatin Capsules Market, pharmaceutical consumption accounts for nearly 47% of total capsule usage. More than 14 billion soft gels are produced annually within the U.S., with dietary supplements alone representing 63% of demand. The U.S. leads in production technology, with over 200 facilities manufacturing soft gels, primarily concentrated in states like California, New Jersey, and Florida. Approximately 72% of American adults regularly consume supplements, significantly driving capsule demand. The U.S. holds over 28% of the global soft gelatin capsules market share, positioning it as the single largest national consumer and producer worldwide.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Driver: 62% of demand is driven by rising health supplements and nutraceuticals consumption.
• Major Market Restraint: 41% of manufacturers face restrictions due to gelatin sourcing and religious compliance.
• Emerging Trends: 53% of companies invest in plant-based and non-animal soft gels.
• Regional Leadership: North America dominates with 34% market share.
• Competitive Landscape: Top 10 players collectively hold 49% of the market share.
• Market Segmentation: Pharmaceuticals account for 39%, supplements 54%, and others 7%.
• Recent Development: 45% of new launches in 2024 featured vegetarian soft gels.

Soft Gelatin Capsules Market Trends

The Soft Gelatin Capsules Market Trends highlight rapid adoption of vegetarian capsules, with more than 53% of new supplement launches in 2024 including plant-based soft gels. Nutraceuticals dominate the industry, with 54% of global demand attributed to vitamins, minerals, and herbal formulations. Pharmaceutical applications continue to expand, with oncology and pain management drugs accounting for 22% of new product approvals in soft gel format. Rising awareness of omega-3 fatty acids has resulted in 19% year-over-year growth in fish oil-based soft gels. Technological innovation is another defining trend. Automated encapsulation machines have increased production efficiency by 27% since 2022, while advanced sealing methods reduce leakage incidents by 36%.

Moreover, liquid-fill formulations have grown to 48% of all capsule types due to higher absorption rates compared to powder-fill forms. The Soft Gelatin Capsules Market Forecast shows increasing demand for personalized medicines, with 15% of manufacturers now offering custom dosage formats. Global e-commerce growth has further contributed, as 61% of supplement sales now occur online, supporting higher capsule volumes. These Soft Gelatin Capsules Market Insights demonstrate how innovation and consumer preferences are reshaping capsule development, ensuring steady momentum across both developed and emerging economies.

Soft Gelatin Capsules Market Dynamics

DRIVER

"Rising demand for pharmaceuticals."

The Soft Gelatin Capsules Market Growth is strongly influenced by pharmaceutical usage, accounting for 39% of total consumption globally. More than 2,000 prescription drugs are currently available in soft gel formulations, particularly in oncology, cardiovascular, and neurology. Patient preference for easy-to-swallow forms has boosted compliance rates by 23% compared to tablets. Soft gels offer faster absorption, with 82% of clinical studies reporting higher bioavailability compared to conventional dosage forms. As chronic diseases rise, the pharmaceutical segment drives strong expansion, ensuring consistent growth opportunities for manufacturers.

RESTRAINT

"Challenges in gelatin sourcing."

The Soft Gelatin Capsules Market Restraints revolve around religious, cultural, and dietary restrictions. Approximately 41% of global consumers in regions like the Middle East, South Asia, and parts of Europe prefer non-animal-based alternatives due to halal, kosher, or vegetarian requirements. Additionally, the supply chain for high-quality bovine and porcine gelatin faces volatility, with raw material shortages increasing costs by nearly 28% in the past three years. Regulatory restrictions add another barrier, with 17% of manufacturers reporting delays due to compliance challenges, reducing overall production efficiency across the industry.

OPPORTUNITY

"Growth in personalized medicines."

The Soft Gelatin Capsules Market Opportunities are increasingly linked to personalized nutrition and medicines. Customized formulations now represent 15% of capsule production, with demand rising for age-specific, gender-specific, and condition-specific soft gels. In the nutraceutical segment, personalized vitamins and dietary supplements already account for 11% of total online supplement sales. In pharmaceuticals, advancements in precision medicine have led to over 160 new soft gel-based clinical trials worldwide. These personalized approaches enhance adherence by 26% compared to generalized medications, opening opportunities for targeted therapy capsules and bespoke supplement solutions.

CHALLENGE

"Rising costs and expenditures."

One of the major Soft Gelatin Capsules Market Challenges is the increasing cost of raw materials, manufacturing, and regulatory compliance. Gelatin price volatility has risen by 21% since 2020, directly impacting capsule pricing. Furthermore, energy-intensive encapsulation processes raise operational expenditures by 19% annually for large-scale facilities. Compliance with stringent regulations across the U.S., EU, and Asia-Pacific also requires an average of 12 months for approvals, delaying time-to-market for new products. With approximately 33% of small-scale manufacturers struggling with financial constraints, the challenge of balancing quality, compliance, and affordability remains a pressing concern.

Soft Gelatin Capsules Market Segmentation Analysis

The Soft Gelatin Capsules Market Segmentation is defined by type and application, influencing global production and consumption patterns. Soft gels are broadly categorized into Dropping Method and Pressing Method capsules, while applications span pharmaceuticals, health supplements, and other specialized uses.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Dropping Method: accounts for 57% of global production, making it the dominant manufacturing technique. It is widely used for encapsulating oils, vitamins, and lipid-soluble drugs due to its high accuracy and uniformity. Approximately 28 billion soft gels are produced annually through this method, with 72% directed toward dietary supplements.

The dropping method segment in the soft gelatin capsules market is projected to achieve a market size of USD 2,945.11 million by 2034, holding nearly 33% share, advancing at a steady CAGR of 5.8% throughout the forecast timeframe.

Top 5 Major Dominant Countries in the Dropping Method Segment

• United States: The U.S. dropping method market is forecasted to reach USD 720.55 million by 2034, capturing a 24.4% share, with consistent growth at a CAGR of 5.7% driven by pharmaceutical innovations.
• Germany: Germany’s dropping method market is anticipated at USD 380.12 million by 2034, accounting for 12.9% share, progressing with a CAGR of 5.5% due to strong nutraceutical demand.
• China: China is set to record USD 460.22 million by 2034, attaining 15.6% share, expanding at CAGR of 6.3% supported by supplement consumption.
• India: India’s market for dropping method capsules is estimated at USD 320.18 million by 2034, achieving 10.9% share, with a growth trajectory at CAGR of 6.1%.
• Japan: Japan will generate USD 280.15 million by 2034, securing 9.5% share, advancing steadily with a CAGR of 5.6% driven by an aging population.

Pressing Method: represents 43% of soft gel output and is commonly used for liquid and suspension fillings. Approximately 21 billion capsules are manufactured each year using pressing techniques. This method offers flexibility, accommodating both pharmaceutical drugs and cosmetic supplements. Around 46% of specialty drugs in soft gel form rely on pressing methods due to their ability to handle sensitive formulations.

The pressing method segment of the soft gelatin capsules market is estimated to reach USD 5,972.63 million by 2034, capturing a dominant 67% share, growing at a robust CAGR of 6.2% over the forecast period.

• Top 5 Major Dominant Countries in the Pressing Method Segment
• United States: U.S. pressing method market will reach USD 1,450.25 million by 2034, holding a 24.3% share, expanding at CAGR of 6.1% owing to advanced pharmaceutical manufacturing.
• Germany: Germany is projected at USD 690.15 million by 2034, securing 11.6% share, progressing with CAGR of 5.9% due to strong drug development.
• China: China’s pressing method segment will achieve USD 870.20 million by 2034, representing 14.6% share, growing strongly at CAGR of 6.5% driven by supplement exports.
• India: India is anticipated to record USD 640.13 million by 2034, with 10.7% share, advancing at CAGR of 6.4% supported by increasing domestic nutraceutical production.
• Japan: Japan is set at USD 520.16 million by 2034, holding 8.7% share, expanding steadily at CAGR of 5.8% due to elderly healthcare focus.

BY APPLICATION

Pharmaceutical: segment accounts for 39% of total soft gel demand. More than 2,000 active pharmaceutical ingredients are marketed in soft gel form, particularly for pain management, oncology, and infectious diseases. Clinical studies show that 83% of patients prefer soft gels over tablets for chronic medications. North America and Europe dominate pharmaceutical applications, with over 70% of FDA and EMA-approved capsule drugs being produced in these regions.

The pharmaceutical application of soft gelatin capsules is expected to reach USD 4,890.33 million by 2034, commanding around 55% share, growing steadily at a CAGR of 6.0% with broad drug delivery uses.

Top 5 Major Dominant Countries in the Pharmaceutical Application

• United States: U.S. pharmaceutical soft gelatin capsules market will hit USD 1,200.21 million by 2034, securing 24.5% share, expanding at CAGR of 6.1% from prescription drugs.
• Germany: Germany’s market is estimated at USD 580.18 million by 2034, attaining 11.8% share, advancing at CAGR of 5.8% due to specialty pharma demand.
• China: China will reach USD 690.22 million by 2034, capturing 14.1% share, recording CAGR of 6.3% fueled by drug export growth.
• India: India is set to achieve USD 540.14 million by 2034, holding 11% share, progressing at CAGR of 6.2% driven by cost-effective production.
• Japan: Japan will generate USD 470.16 million by 2034, representing 9.6% share, expanding at CAGR of 5.7% from rising chronic illness treatments.

Health Supplements: remain the largest segment, contributing 54% of global soft gel consumption. Vitamins A, D, E, and K, omega-3 fatty acids, and herbal extracts dominate this category, with 67% of supplement brands offering at least one soft gel-based product. Online distribution channels represent 61% of sales, demonstrating a strong consumer preference for convenient soft gel delivery. In countries like China and the U.S., soft gels account for nearly 70% of all omega-3 supplement sales, highlighting their widespread popularity.

The health supplements application segment is forecasted to attain USD 3,920.14 million by 2034, covering nearly 44% share, growing at a strong CAGR of 6.3% driven by wellness and preventive healthcare.

Top 5 Major Dominant Countries in the Health Supplements Application

• United States: The U.S. supplements market is anticipated at USD 1,010.19 million by 2034, capturing 25.7% share, rising at CAGR of 6.2% with high consumer health awareness.
• Germany: Germany will reach USD 510.12 million by 2034, attaining 13% share, expanding at CAGR of 5.9% supported by dietary supplement trends.
• China: China’s health supplement capsules market will hit USD 600.25 million by 2034, representing 15.3% share, advancing with CAGR of 6.4%.
• India: India is estimated at USD 430.17 million by 2034, securing 11% share, growing with CAGR of 6.3% on account of herbal supplement demand.
• Japan: Japan’s market will be USD 360.11 million by 2034, with 9.2% share, growing at CAGR of 5.8% due to aging wellness trends.

Other Applications: category makes up 7% of market demand, covering cosmetics, veterinary medicines, and specialty products. Approximately 3 billion soft gels annually are produced for non-pharmaceutical and non-supplement uses, including beauty formulations, CBD products, and pet supplements. In the veterinary sector alone, soft gels now represent 9% of encapsulated drug delivery formats.

Other applications of soft gelatin capsules, including cosmetics and specialty uses, are forecasted to reach USD 107.27 million by 2034, maintaining a modest 1% share, progressing at CAGR of 5.5%.

Top 5 Major Dominant Countries in Other Applications

• United States: The U.S. segment is projected at USD 25.20 million by 2034, holding 23.5% share, growing at CAGR of 5.4% in niche applications.
• Germany: Germany will achieve USD 11.80 million by 2034, capturing 11% share, advancing at CAGR of 5.2%.
• China: China’s market is estimated at USD 16.20 million by 2034, accounting for 15.1% share, expanding at CAGR of 5.6%.
• India: India will reach USD 10.90 million by 2034, attaining 10.2% share, progressing at CAGR of 5.5%.
• Japan: Japan is expected to generate USD 9.50 million by 2034, holding 8.8% share, advancing at CAGR of 5.3%.

Soft Gelatin Capsules Market Regional Outlook

The Soft Gelatin Capsules Market Analysis varies significantly across regions, shaped by consumer preferences, regulatory environments, and production capabilities. Market share distribution demonstrates clear leadership in developed regions, while emerging markets show strong growth potential.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

leads the global Soft Gelatin Capsules Market, with a commanding 34% market share in 2024. The U.S. dominates within the region, accounting for nearly 82% of North American demand, while Canada contributes around 12% and Mexico 6%. Over 14 billion soft gelatin capsules are produced annually in the U.S. alone, supported by more than 200 large-scale manufacturing facilities concentrated in states such as California, New Jersey, and Texas.

The North American soft gelatin capsules market is projected to reach USD 2,520.18 million by 2034, accounting for nearly 28.3% share, expanding at a CAGR of 6.1% supported by strong pharmaceutical innovation and rising dietary supplement demand.

North America - Major Dominant Countries in the “Soft Gelatin Capsules Market”

• United States: The U.S. market is expected to achieve USD 2,000.15 million by 2034, holding 23% share, growing at CAGR of 6.1% driven by robust pharmaceutical R&D and high consumer adoption of supplements.
• Canada: Canada is forecasted at USD 260.12 million by 2034, capturing 3% share, expanding at CAGR of 5.8% owing to increasing nutraceutical use and expanding healthcare accessibility.
• Mexico: Mexico is set to reach USD 150.09 million by 2034, securing 1.7% share, advancing at CAGR of 5.7% due to rising demand for affordable generic drugs and wellness products.
• Cuba: Cuba’s market is projected at USD 65.05 million by 2034, contributing 0.7% share, growing at CAGR of 5.5% from gradually improving healthcare systems.
• Dominican Republic: The Dominican Republic will record USD 45.03 million by 2034, accounting for 0.5% share, progressing at CAGR of 5.4% with growth in imports of dietary supplements.

EUROPE

holds approximately 28% share of the Soft Gelatin Capsules Industry, ranking as the second-largest regional market. Germany, the UK, France, and Italy collectively account for more than 70% of Europe’s soft gel demand. Germany alone produces over 5 billion capsules annually, supported by advanced pharmaceutical manufacturing clusters in regions like Bavaria and North Rhine-Westphalia.

Europe’s soft gelatin capsules market is anticipated to reach USD 2,410.20 million by 2034, contributing about 27% share, expanding at a steady CAGR of 5.9% due to advancements in pharmaceutical manufacturing and growing preventive healthcare adoption.

Europe - Major Dominant Countries in the “Soft Gelatin Capsules Market”

• Germany: Germany is estimated at USD 1,100.12 million by 2034, holding 12.5% share, expanding at CAGR of 5.9% driven by strong demand in pharma and nutraceutical industries.
• United Kingdom: The UK market will reach USD 650.10 million by 2034, securing 7.3% share, growing at CAGR of 5.8% due to high supplement penetration rates.
• France: France is forecasted to record USD 360.08 million by 2034, representing 4% share, progressing at CAGR of 5.6% with emphasis on prescription drug innovations.
• Italy: Italy will achieve USD 200.07 million by 2034, with 2.2% share, expanding at CAGR of 5.5% from rising supplement consumption.
• Spain: Spain’s market is projected at USD 100.05 million by 2034, contributing 1.1% share, growing at CAGR of 5.4% supported by healthcare modernization.

ASIA-PACIFIC

region accounts for 29% of the Soft Gelatin Capsules Market Share, positioning it as one of the fastest-growing markets globally. China leads within the region, contributing nearly 41% of total Asia-Pacific demand, followed by India at 27%, Japan at 15%, and South Korea at 9%. China alone manufactures over 10 billion soft gels annually, supported by over 350 capsule production facilities.

Asia’s soft gelatin capsules market is forecasted to reach USD 2,940.21 million by 2034, capturing the largest 33% share, expanding at a strong CAGR of 6.4% driven by high supplement usage and cost-effective pharmaceutical production.

Asia - Major Dominant Countries in the “Soft Gelatin Capsules Market”

• China: China will achieve USD 1,500.15 million by 2034, with 16.8% share, advancing at CAGR of 6.4% supported by large-scale nutraceutical demand.
• India: India is projected at USD 1,000.12 million by 2034, holding 11.2% share, growing at CAGR of 6.3% due to rising supplement exports and domestic demand.
• Japan: Japan’s market is set to record USD 700.10 million by 2034, with 7.8% share, expanding at CAGR of 5.8% driven by healthcare needs of an aging population.
• South Korea: South Korea will generate USD 400.09 million by 2034, accounting for 4.5% share, progressing at CAGR of 6.1% with strong preventive healthcare trends.
• Indonesia: Indonesia is anticipated at USD 220.07 million by 2034, securing 2.5% share, expanding at CAGR of 5.9% driven by growing supplement imports.

MIDDLE EAST & AFRICA

represents 9% of the global Soft Gelatin Capsules Market Size, but its potential is expanding. The United Arab Emirates and Saudi Arabia account for 52% of regional demand, while South Africa represents another 18%. Capsule consumption in the Gulf region is largely driven by health supplements, which make up 64% of demand. Pharmaceutical soft gels account for 29%, while veterinary and specialty uses comprise the remainder.

The Middle East and Africa soft gelatin capsules market is estimated at USD 1,047.15 million by 2034, accounting for 12% share, growing at a steady CAGR of 5.7% supported by increasing healthcare spending and expanding pharma distribution.

Middle East and Africa - Major Dominant Countries in the “Soft Gelatin Capsules Market”

• United Arab Emirates: UAE is forecasted at USD 260.10 million by 2034, holding 3% share, expanding at CAGR of 5.9% with rising demand for premium supplements.
• Saudi Arabia: Saudi Arabia will reach USD 250.09 million by 2034, securing 2.8% share, advancing at CAGR of 5.8% due to high healthcare investments.
• South Africa: South Africa is expected to achieve USD 200.08 million by 2034, with 2.2% share, expanding at CAGR of 5.6% supported by chronic disease treatments.
• Egypt: Egypt will record USD 180.07 million by 2034, capturing 2% share, growing at CAGR of 5.5% from expanding supplement markets.
• Nigeria: Nigeria is projected at USD 157.06 million by 2034, with 1.8% share, progressing at CAGR of 5.4% supported by increasing demand for affordable nutraceuticals.

List of Top Soft Gelatin Capsules Companies

• NBTY
• Strides Arcolab
• Baihe Biotech
• Donghai Pharm
• Soft Gel Technologies
• Aenova
• Amway
• Guangdong Yichao
• Catalent
• Procaps
• Yuwang Group
• Captek
• IVC
• By-Health
• Shineway
• Sirio Pharma
• Patheon Inc
• EuroCaps
• Capsugel
• Ziguang Group

Catalent: holds approximately 14% of the global Soft Gelatin Capsules Market Share, supported by more than 40 manufacturing facilities worldwide and an annual output of over 25 billion capsules. The company specializes in pharmaceutical soft gels, accounting for 58% of its portfolio.

Aenova: controls nearly 11% of the global market, producing over 18 billion soft gels annually. Its European operations dominate, with Germany contributing 38% of its total production capacity. Approximately 61% of Aenova’s capsules are health supplement-focused.

Investment Analysis and Opportunities

The Soft Gelatin Capsules Market Investment Analysis indicates strong opportunities for both established players and new entrants. Global demand exceeds 42 billion capsules annually, with nutraceuticals accounting for 54% and pharmaceuticals 39%. Investment in automated encapsulation lines has grown by 27% since 2022, reducing production costs and increasing capacity utilization rates to 78%. Emerging economies present major opportunities. In Asia-Pacific, where capsule consumption has grown by 19% in three years, foreign investments are focused on India and China. India’s export share of soft gels has reached 23% of total production, attracting contract manufacturing partnerships from North America and Europe.

Plant-based capsules represent another attractive opportunity. Currently, vegetarian soft gels comprise 12% of the total market, but demand is rising at double-digit levels. Companies investing in alternative raw materials, such as seaweed and starch-based polymers, have seen product launches increase by 42% in the past two years. Digital health and online retail channels also create investment avenues, as 61% of supplement sales globally now occur online. Strategic partnerships in e-commerce and direct-to-consumer models are forecast to further boost the Soft Gelatin Capsules Market Growth, making this a promising sector for long-term investments.

New Product Development

Innovation remains central to the Soft Gelatin Capsules Industry Report, with manufacturers introducing advanced formulations and eco-friendly materials. In 2024, nearly 45% of new product launches featured vegetarian or vegan capsules, addressing the rising demand among health-conscious and religious consumers. Seaweed and tapioca starch are increasingly used as gelatin alternatives, with 22% of companies adopting these raw materials in production. Pharmaceutical innovation is also strong. More than 120 new drug approvals between 2021 and 2024 incorporated soft gels, with oncology, neurology, and cardiovascular drugs leading adoption. Controlled-release formulations have expanded, now representing 17% of pharmaceutical soft gel approvals. These advances improve drug delivery efficiency and patient adherence.

In nutraceuticals, omega-3, collagen, and herbal extracts dominate new launches. Collagen-based soft gels have seen a 26% increase in production since 2022, driven by “beauty-from-within” trends. Pediatric and geriatric-friendly capsule sizes also represent growing development areas, with 19% of launches focusing on smaller, easier-to-swallow formats. Sustainability is an emerging theme, with 33% of manufacturers in 2024 committing to recyclable packaging for soft gel products. Collectively, these innovations highlight the direction of Soft Gelatin Capsules Market Trends, emphasizing health, convenience, and sustainability.

Five Recent Developments

• In 2023, Catalent expanded its manufacturing in the U.S., increasing annual capacity by 20%, enabling the production of over 30 billion soft gels.
• In 2024, Aenova launched a new line of vegetarian capsules, with 40% of its supplement portfolio now plant-based.
• Procaps announced in 2024 the acquisition of two regional capsule manufacturers in Latin America, boosting its market share by 7%.
• In 2025, Sirio Pharma introduced collagen-based soft gels, achieving 18% growth in beauty supplement sales.
• Baihe Biotech unveiled automated encapsulation technology in 2025, reducing defect rates by 22% and increasing productivity by 15%.

Report Coverage of Soft Gelatin Capsules Market

The Soft Gelatin Capsules Market Research Report provides comprehensive coverage of industry performance, opportunities, and future outlook. It evaluates global consumption of over 42 billion capsules annually, segmented by type, application, and geography. Key insights include analysis of Dropping Method and Pressing Method capsules, which account for 57% and 43% of production respectively, and applications spanning pharmaceuticals (39%), health supplements (54%), and other uses (7%). The report examines regional markets in detail, highlighting North America’s 34% share, Europe’s 28%, Asia-Pacific’s 29%, and the Middle East & Africa’s 9%.

Consumer behavior trends are analyzed, including the 72% adult supplement usage rate in the U.S. and the 38% vegetarian preference in Europe. Competitive landscape analysis identifies leading players, with Catalent holding 14% and Aenova 11% of global share. It also outlines recent innovations such as plant-based capsules and collagen-based formulations. Investment opportunities are explored in emerging markets like India and China, which account for nearly 70% of Asia-Pacific consumption.

Soft Gelatin Capsules Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 5576.17 Million in 2026
Market Size Value By	USD 9456.37 Million by 2035
Growth Rate	CAGR of 6.04% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Dropping Method Pressing Method By Application : Pharmaceutical Health Supplements Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample